Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PSD503: Preliminary Phase II data

Preliminary data from a double-blind Phase II study in 12 women with SUI showed

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE